Sleep quality predicts quality of life and mortality risk in haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
S. J. Elder(SHOWA Medical University), Rajiv Saran(University of Michigan), R. B. Fissell(University of Michigan), Hugh C. Rayner(Heartlands Hospital), A Furniss(Arbor Research Collaborative for Health), Tadao Akizawa(Showa University), Shizuko Fukuhara(Kyoto University), F. K. Port(SHOWA Medical University), K. Kurokawa(Tokai University), Vittorio E. Andreucci, R. L. Pisoni(Arbor Research Collaborative for Health)
Cited by 322
Related Papers
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
|American Journal of Kidney Diseases|1998|2.4k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2006|628
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS
|Kidney International|2006|453